Q2 Earnings Forecast for Clorox Issued By DA Davidson

The Clorox Company (NYSE:CLX) – Equities researchers at DA Davidson issued their Q2 2025 EPS estimates for shares of Clorox in a note issued to investors on Monday, November 4th. DA Davidson analyst L. Weiser forecasts that the company will post earnings of $1.27 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $171.00 price target on the stock. The consensus estimate for Clorox’s current full-year earnings is $6.79 per share.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period last year, the firm posted $0.49 earnings per share.

A number of other brokerages also recently weighed in on CLX. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Wells Fargo & Company cut their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Finally, Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $151.57.

Clorox Stock Down 0.4 %

Shares of NYSE:CLX opened at $162.48 on Tuesday. The business has a fifty day simple moving average of $161.63 and a 200 day simple moving average of $146.33. Clorox has a 12-month low of $125.46 and a 12-month high of $169.09. The firm has a market cap of $20.11 billion, a P/E ratio of 56.61, a P/E/G ratio of 3.09 and a beta of 0.41. The company has a quick ratio of 0.63, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.00%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. First Foundation Advisors purchased a new position in Clorox in the 1st quarter worth approximately $31,000. Innealta Capital LLC purchased a new position in shares of Clorox in the second quarter worth $30,000. Trifecta Capital Advisors LLC raised its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the last quarter. Quarry LP boosted its position in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Family Firm Inc. bought a new stake in shares of Clorox in the 2nd quarter worth approximately $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.